Effect of Exercises on Hemodialysis

December 20, 2025 updated by: Faten Mahmoud, Cairo University

Effect of Intra Dialytic Aerobic Exercises Versus Active Free Exercises on Cognitive Function and Functional Capacity in Hemodialytic Patients

o Sixty-nine adult patients from both sexes. They were suffering from ESRD on maintenance hemodialysis, their age ranged from50-60 years old were selected from hemodialysis unit at Itay El Baroud central hospital. They were referred by the physician.

Study Overview

Detailed Description

Ⅰ-Subjects:

o Sixty-nine adult patients from both sexes. They were suffering from ESRD on maintenance hemodialysis, their age ranged from50-60 years old were selected from hemodialysis unit at Itay El Baroud central hospital. They were referred by the physician.

Study group (A): the study group consisted of (23) patients who received aerobic exercise in form of (foot pedal exerciser) for 20 Minutes for each session, 3 sessions per week, for 8 weeks plus maintain on their medical treatment and hemodialysis.

Study group (B): the study group consisted of (23) who received active free range of motion exercise (open kinetic chain active free range of motion) for 20 minutes for each session, 3 sessions per week, for 8 weeks plus maintain on their medical treatment and hemodialysis.

Control group (C): the control group consisted of (23) patients who were maintained on their medical treatment and hemodialysis.

II- Instrumentation 6-Minutes walk test: The 6-min walk test (6MWT) is frequently used to measure physical function in transplanted patients.

  • Fatigue Questionnaire (Fatigue Severity Scale) it was used to assess the level of fatigue.
  • Laboratory investigation: urea and creatinine are commonly used to monitor the effects of exercise on urea clearance and kidney function improvement in transplant patients.
  • The Mini-Cog test: is a quick, simple, and effective screening tool for early cognitive impairment in hemodialysis patients, making it ideal for busy clinical settings.

B-Therapeutic Equipment:

Foot pedal exerciser (fig.9):

  • Simple horizontal foot pedal exerciser used during hemodialysis sessions.
  • Dual pedals with non-slip straps for foot stability.
  • Manual resistance adjustment via a single control knob (non-electric).
  • Provides gradual increase in workload intensity.
  • Compact and light weight design suitable for use while lying on the dialysis bed.
  • Enables controlled, low-impact circular movement of the feet.
  • Aims to improve circulation and strengthen lower limb muscles without requiring active sitting.
  • Approximate device dimensions: 50 cm (length) x 40 cm (width) x 23 cm (height).
  • Maximum recommended user weight: 70 kg. Participants completed the 30-min aerobic exercise sessions during the first 2 hrs. of each dialysis session, 3 times per week for 8 weeks, using a simulated bike riding. Patients will perform active free exercise for upper limb (the arm that hasn't shunt) and lower limbs. Each exercise session consisted of three phases: warm up, conditioning, and cool down.

Study Type

Interventional

Enrollment (Estimated)

69

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Research Ethical Committee, Principal Investigator
  • Phone Number: 01151312322
  • Email: eth.com@pt.cu.edu.eg

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

All patients were included according to the following criteria:

  1. Age between 50-60years.
  2. The patients had been on hemodialysis for at least 3 months with three sessions per week for 3-4hr per session.
  3. The patients were diagnosed with end stage renal failure (stage5 CKD) on maintenance regular HD (three sessions/week (on alternate days), for four hours/session) for more than three months. (Receiving HD through uncomplicated arm arteriovenous (A-V) fistula
  4. Under medical control
  5. Both men and women were enrolled
  6. Body math index ranged from 18,5- 24.9 kg/m²

Exclusion Criteria:

Patients who experienced or had one or more of the following were excluded from the study:

  1. Patients with resting systolic blood pressure >200 mmHg and/or diastolic blood pressure >120 mmHg.
  2. patients with neurological problems (e.g. stroke, head injury)
  3. patients with musculoskeletal problems (e.g. sever osteoarthritis or difficulties in ambulation)
  4. Patients with uncontrolled pulmonary disease. (e.g. exaggerated chronic obstructive pulmonary disease, acute asthma)
  5. Patients with mental health problems and cognitive impairment due to inability to teach them how to make respiratory training.
  6. Any patient who missed more than two weeks of the program or want to terminate the program.
  7. Severe obesity (BMI >35)
  8. Presence of malignant disease.
  9. Patients with unstable angina, uncontrolled cardiac arrhythmia, decompensated heart failure, acute pericarditis or myocarditis.
  10. The patients had hearing impairment or mental disorders.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Aerobic exercise
(23) patients who received aerobic exercise in form of (foot pedal exerciser) for 20 Minutes for each session, 3 sessions per week, for 8 weeks.

Foot pedal exerciser:

  • Simple horizontal foot pedal exerciser used during hemodialysis sessions.
  • Dual pedals with non-slip straps for foot stability.
  • Manual resistance adjustment via a single control knob (non-electric).
  • Provides gradual increase in workload intensity.
  • Compact and light weight design suitable for use while lying on the dialysis bed.
  • Enables controlled, low-impact circular movement of the feet.
  • Aims to improve circulation and strengthen lower limb muscles without requiring active sitting.
  • Approximate device dimensions: 50 cm (length) x 40 cm (width) x 23 cm (height).
  • Maximum recommended user weight: 70 kg.
Experimental: Active free range of motion exercise
(23) patients who received active free range of motion exercise (open kinetic chain active free range of motion) for 20 minutes for each session, 3 sessions per week, for 8 weeks.
Participants completed the 30-min aerobic exercise sessions during the first 2 hrs. of each dialysis session, 3 times per week for 8 weeks, using a simulated bike riding. Patients will perform active free exercise for upper limb (the arm that hasn't shunt) and lower limbs. Each exercise session consisted of three phases: warm up, conditioning, and cool down.
Other: control group
(23) patients who will receive standard medical treatment for end-stage renal disease, including regular hemodialysis sessions and pharmacological management (e.g., Epoetin alfa and phosphate binders) as prescribed by their nephrologist, without participating in the physical therapy exercise program.
the control group will receive only the standard medical care provided by dialysis center without any physical therapy intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fatigue Questionnaire (Fatigue Severity Scale)
Time Frame: 8 weeks
The Fatigue Severity Scale it used to assess the level of fatigue. The Fatigue Severity Scale scores range from 9 to 36 where higher scores indicate worse fatigue and lower scores indicate improvement in fatigue.
8 weeks
6-Minutes walk test
Time Frame: 8 weeks
The 6-min walk test (6MWT) is frequently used to measure physical function in transplanted patients
8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Laboratory investigation (Urea analysis)
Time Frame: 8 weeks
Urea analysis is commonly used to monitor the effects of exercise on urea clearance and kidney function
8 weeks
The Mini-Cog test
Time Frame: 8 weeks
The Mini-Cog test is a quick, simple, and effective screening tool for early cognitive impairment in hemodialysis patients, making it ideal for busy clinical settings. The Mini-Cog Test scores range from 0 to 5, where higher scores indicate better cognitive performance, and lower scores suggest potential cognitive impairment.
8 weeks
Laboratory investigation (creatinine analysis)
Time Frame: 8 weeks
creatinine analysis is used to be monitor the effects of exercise on creatinine clearance and kidney function
8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Research Ethical Committee Cairo University, Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 1, 2026

Primary Completion (Estimated)

May 1, 2026

Study Completion (Estimated)

June 1, 2026

Study Registration Dates

First Submitted

December 9, 2025

First Submitted That Met QC Criteria

December 20, 2025

First Posted (Actual)

January 6, 2026

Study Record Updates

Last Update Posted (Actual)

January 6, 2026

Last Update Submitted That Met QC Criteria

December 20, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hemodialytic Patients

Clinical Trials on Aerobic exercises

Subscribe